Filing Details

Accession Number:
0000919574-22-005788
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-05 16:24:22
Reporting Period:
2022-10-03
Accepted Time:
2022-10-05 16:24:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1287098 Maxcyte Inc. MXCT Services-Commercial Physical & Biological Research (8731) 522210438
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1534260 Casdin Partners Gp, Llc 1350 Avenue Of The Americas
Suite 2600
New York NY 10019
No No Yes No
1534261 Casdin Capital, Llc 1350 Avenue Of The Americas
Suite 2600
New York NY 10019
No No Yes No
1534264 Eli Casdin 1350 Avenue Of The Americas
Suite 2600
New York NY 10019
No No Yes No
1534265 Casdin Partners Master Fund, L.p. 1350 Avenue Of The Americas
Suite 2600
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Disposition 2022-10-03 735,786 $6.15 10,000,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. (1) The securities are owned directly by Casdin Partners Master Fund, LP (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.